212 related articles for article (PubMed ID: 16111713)
1. Ethnic differences in CYP2C9*2 (Arg144Cys) and CYP2C9*3 (Ile359Leu) genotypes in Japanese and Israeli populations.
Nakai K; Habano W; Nakai K; Fukushima N; Suwabe A; Moriya S; Osano K; Gurwitz D
Life Sci; 2005 Nov; 78(1):107-11. PubMed ID: 16111713
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation of three tetrameric tandem repeats in four distinct Israeli ethnic groups.
Amar A; Brautbar C; Motro U; Fisher T; Bonne-Tamir B; Israel S
J Forensic Sci; 1999 Sep; 44(5):983-6. PubMed ID: 10486950
[TBL] [Abstract][Full Text] [Related]
3. Interethnic differences of CYP2C9 alleles in healthy Hungarian and Roma population samples: relationship to worldwide allelic frequencies.
Sipeky C; Lakner L; Szabo M; Takacs I; Tamasi V; Polgar N; Falus A; Melegh B
Blood Cells Mol Dis; 2009; 43(3):239-42. PubMed ID: 19541511
[TBL] [Abstract][Full Text] [Related]
4. Ethnic differences of coronary artery disease-associated SNPs in two Israeli healthy populations using MALDI-TOF mass spectrometry.
Nakai K; Habano W; Nakai K; Fukushima N; Fujita T; Gurwitz D
Life Sci; 2004 Jul; 75(8):1003-10. PubMed ID: 15193960
[TBL] [Abstract][Full Text] [Related]
5. Frequency of LCT-13910C/T and LCT-22018G/A single nucleotide polymorphisms associated with adult-type hypolactasia/lactase persistence among Israelis of different ethnic groups.
Raz M; Sharon Y; Yerushalmi B; Birk R
Gene; 2013 Apr; 519(1):67-70. PubMed ID: 23415628
[TBL] [Abstract][Full Text] [Related]
6. Validation of methods for CYP2C9 genotyping: frequencies of mutant alleles in a Swedish population.
Yasar U; Eliasson E; Dahl ML; Johansson I; Ingelman-Sundberg M; Sjöqvist F
Biochem Biophys Res Commun; 1999 Jan; 254(3):628-31. PubMed ID: 9920790
[TBL] [Abstract][Full Text] [Related]
7. Rapid detection of CYP2C9*3 alleles by real-time fluorescence PCR based on SYBR Green.
Hiratsuka M; Agatsuma Y; Mizugaki M
Mol Genet Metab; 1999 Nov; 68(3):357-62. PubMed ID: 10562462
[TBL] [Abstract][Full Text] [Related]
8. Identification of a synonymous polymorphism within the cytochrome P4502C9 gene that interferes with identification of the CYP2C9*2 allele.
Womack EP; Reynolds KK; Valdes R; Linder MW
Ther Drug Monit; 2007 Oct; 29(5):607-11. PubMed ID: 17898651
[TBL] [Abstract][Full Text] [Related]
9. Ethnic differences in the VKORC1 gene polymorphism and an association with warfarin dosage requirements in cardiovascular surgery patients.
Nakai K; Tsuboi J; Okabayashi H; Fukuhiro Y; Oka T; Habano W; Fukushima N; Nakai K; Obara W; Fujioka T; Suwabe A; Gurwitz D
Pharmacogenomics; 2007 Jul; 8(7):713-9. PubMed ID: 18240904
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of CYP2C19 and CYP2D6 in Israeli ethnic groups.
Luo HR; Aloumanis V; Lin KM; Gurwitz D; Wan YJ
Am J Pharmacogenomics; 2004; 4(6):395-401. PubMed ID: 15651900
[TBL] [Abstract][Full Text] [Related]
11. CYP2C9 genotype as a predictor of drug disposition in humans.
Lee CR
Methods Find Exp Clin Pharmacol; 2004; 26(6):463-72. PubMed ID: 15349140
[TBL] [Abstract][Full Text] [Related]
12. Reconstruction of patrilineages and matrilineages of Samaritans and other Israeli populations from Y-chromosome and mitochondrial DNA sequence variation.
Shen P; Lavi T; Kivisild T; Chou V; Sengun D; Gefel D; Shpirer I; Woolf E; Hillel J; Feldman MW; Oefner PJ
Hum Mutat; 2004 Sep; 24(3):248-60. PubMed ID: 15300852
[TBL] [Abstract][Full Text] [Related]
13. Impact of CYP2C9 amino acid polymorphisms on glyburide kinetics and on the insulin and glucose response in healthy volunteers.
Kirchheiner J; Brockmöller J; Meineke I; Bauer S; Rohde W; Meisel C; Roots I
Clin Pharmacol Ther; 2002 Apr; 71(4):286-96. PubMed ID: 11956512
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of CYP2C9 polymorphisms in the south of Europe.
Sánchez-Diz P; Estany-Gestal A; Aguirre C; Blanco A; Carracedo A; Ibáñez L; Passiu M; Provezza L; Ramos-Ruiz R; Ruiz B; Salado-Valdivieso I; Velasco EA; Figueiras A
Pharmacogenomics J; 2009 Oct; 9(5):306-10. PubMed ID: 19381164
[TBL] [Abstract][Full Text] [Related]
15. [Influence of cytochrom P450 CYP2C9 polymorphism on the pharmacokinetics of tolbutamide metabolism using oligonucleotide genotyping microarray].
Li J; Wen SY; Wang R; Chen K; Fang Y; Pei F; Wang SQ
Yao Xue Xue Bao; 2005 Aug; 40(8):695-9. PubMed ID: 16268502
[TBL] [Abstract][Full Text] [Related]
16. [A new, rapid and robust genotyping method for CYP2C9 and MDR1].
Verstuyft C; Morin S; Yang J; Loriot MA; Barbu V; Kerb R; Brinkmann U; Beaune P; Jaillon P; Becquemont L
Ann Biol Clin (Paris); 2003; 61(3):305-9. PubMed ID: 12805007
[TBL] [Abstract][Full Text] [Related]
17. Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms.
Pilotto A; Seripa D; Franceschi M; Scarcelli C; Colaizzo D; Grandone E; Niro V; Andriulli A; Leandro G; Di Mario F; Dallapiccola B
Gastroenterology; 2007 Aug; 133(2):465-71. PubMed ID: 17681167
[TBL] [Abstract][Full Text] [Related]
18. Frequency of CYP2C9 polymorphisms affecting warfarin metabolism in a large anticoagulant clinic cohort.
Moridani M; Fu L; Selby R; Yun F; Sukovic T; Wong B; Cole DE
Clin Biochem; 2006 Jun; 39(6):606-12. PubMed ID: 16630605
[TBL] [Abstract][Full Text] [Related]
19. Highly variable incidence of cystic fibrosis and different mutation distribution among different Jewish ethnic groups in Israel.
Kerem E; Kalman YM; Yahav Y; Shoshani T; Abeliovich D; Szeinberg A; Rivlin J; Blau H; Tal A; Ben-Tur L
Hum Genet; 1995 Aug; 96(2):193-7. PubMed ID: 7635469
[TBL] [Abstract][Full Text] [Related]
20. Application of HLA-DRB1 genotyping by oligonucleotide micro-array technology in forensic medicine.
Jiang B; Li Y; Wu H; He X; Li C; Li L; Tang R; Xie Y; Mao Y
Forensic Sci Int; 2006 Oct; 162(1-3):66-73. PubMed ID: 16884876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
